Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 241 - 270 of 315
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
PL	Resepti	Dopmin 40 mg-ml infuusiokonsentraatti, liuosta varten SPC 2021-02-17
		European Medicines Agency's website: Doptelet - EMA: EPAR PI Finnish Swedish
PL	Resepti	Dormicum 7.5 mg, 15 mg tabletti, kalvopäällysteinen SPC 2023-08-10
PL	Resepti	Dormix 12.5 mg, 25 mg tabletti, kalvopäällysteinen SPC 2023-05-23
PL	Resepti	Dorzolamid-Timolol Sandoz 20 mg-ml + 5 mg-ml silmätipat, liuos SPC 2023-03-29
PL	Resepti	Dorzolamide-Timolol Stada 20 mg-ml + 5 mg-ml silmätipat, liuos, kerta-annospakkaus SPC 2023-02-14
PL	Resepti	Dostinex 0,5 mg tabletti SPC 2021-07-07
PL	Resepti	Dotarem 279,3 mg-ml injektioneste, liuos SPC 2023-12-08.doc
PL	Resepti	Dotarem 279,3 mg-ml injektioneste, liuos, esitäytetty ruisku SPC 2023-12-08
		European Medicines Agency's website: Dovato - EMA: EPAR PI Finnish Swedish
PL	Resepti	Doximed 100 mg, 150 mg tabletti SPC 2020-08-21
PL	Resepti	Doximed 100 mg, 150 mg tabletti SPC 2020-08-21
PL	Resepti	Doximycin 100 mg, 150 mg tabletti SPC 2022-12-20
PL	Resepti	Doxitin100 mg tabletti SPC 2022-07-05
PL	Resepti	Doxitin150 mg tabletti SPC 2022-07-05
PL	Resepti	Doxorubicin Accord 2 mg-ml infuusiokonsentraatti, liuosta varten SPC 2024-01-31
PL	Resepti	Doxorubicin medac 2 mg-ml infuusioneste, liuos SPC 2023-03-29
PL	Resepti	Droglican 200 mg - 250 mg kapseli, kova SPC 2022-11-15
PL	Resepti	Dronedarone Stada 400 mg tabletti, kalvopäällysteinen SPC 2021-02-18
PL	Resepti	Droperidol Sintetica 0.5 mg-ml injektioneste, liuos SPC 2023-07-05
PL	Resepti	Dropizol 10 mg-ml tipat, liuos SPC 2022-07-15
PL	Resepti	Drospin Midas 3 mg - 0,03 mg tabletti SPC 2015-06-15
		European Medicines Agency's website: Drovelis - EMA: EPAR PI Finnish Swedish
PL	Resepti	Duact kapseli, kova SPC 2020-09-17
		European Medicines Agency's website: Duaklir Genuair - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Duavive - EMA: EPAR PI Finnish Swedish
PL	Resepti	Ducressa 1 mg-ml + 5 mg-ml silmätipat, liuos SPC 2022-03-24
		European Medicines Agency's website: Dukoral - EMA: EPAR PI Finnish Swedish
PL	Resepti	Duloxetin STADA 20 mg, 40 mg enterokapseli, kova SPC 2021-09-07
PL	Resepti	Duloxetin STADA 30 mg, 60 mg enterokapseli, kova SPC 2021-09-08
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  |  Next 30   >